Novo Nordisk NovoNorm Repaglinide Tablets Package Insert

This document provides information about the composition, characteristics, indications, dosage, and adverse reactions of Repaglinide Tablets.


Novo Nordisk NovoNorm Repaglinide Tablets Package Insert - cover page
Brand
Novo Nordisk
Category
Other
Document type
Other
Language
Chinese
Pages
9
File format
PDF
File size
271 KB
Published
19 September, 2022
Updated
28 September, 2023
MD5 checksum
3207A734BD63BB4569EF63892D357093

About this manual

This document is the official package insert for NovoNorm (Repaglinide Tablets), a medication manufactured by Novo Nordisk for the treatment of Type 2 diabetes in adults. It provides comprehensive information on the drug's composition, indications, and specific usage instructions. This manual is written in Chinese.

What's inside

  • 药品名称
  • 成份
  • 适应症
  • 用法用量
  • 不良反应
  • 禁忌
  • 注意事项
  • 药物相互作用
  • 药理毒理
  • 药代动力学

Specifications

Molecular Weight452.6
Available Strengths0.5mg, 1.0mg, 2.0mg

Frequently asked questions

What is the recommended starting dose for patients switching from other oral hypoglycemic agents?

The recommended starting dose is 1mg before meals.

Which drug is strictly prohibited to use with Repaglinide?

Gemfibrozil is prohibited for concurrent use with Repaglinide.

What is the maximum recommended single dose?

The maximum recommended single dose is 4mg.

Download PDF (271 KB)

More Novo Nordisk Manuals


View all Novo Nordisk manuals →